201 related articles for article (PubMed ID: 11483773)
1. Latent antigen vaccination in a model gammaherpesvirus infection.
Usherwood EJ; Ward KA; Blackman MA; Stewart JP; Woodland DL
J Virol; 2001 Sep; 75(17):8283-8. PubMed ID: 11483773
[TBL] [Abstract][Full Text] [Related]
2. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.
Usherwood EJ; Roy DJ; Ward K; Surman SL; Dutia BM; Blackman MA; Stewart JP; Woodland DL
J Exp Med; 2000 Oct; 192(7):943-52. PubMed ID: 11015436
[TBL] [Abstract][Full Text] [Related]
3. Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection.
Obar JJ; Crist SG; Gondek DC; Usherwood EJ
J Immunol; 2004 Jan; 172(2):1213-9. PubMed ID: 14707099
[TBL] [Abstract][Full Text] [Related]
4. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.
Liu L; Usherwood EJ; Blackman MA; Woodland DL
J Virol; 1999 Dec; 73(12):9849-57. PubMed ID: 10559297
[TBL] [Abstract][Full Text] [Related]
5. Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes.
Husain SM; Usherwood EJ; Dyson H; Coleclough C; Coppola MA; Woodland DL; Blackman MA; Stewart JP; Sample JT
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7508-13. PubMed ID: 10377445
[TBL] [Abstract][Full Text] [Related]
6. Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant.
Boname JM; Coleman HM; May JS; Stevenson PG
J Gen Virol; 2004 Jan; 85(Pt 1):131-135. PubMed ID: 14718627
[TBL] [Abstract][Full Text] [Related]
7. T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics.
Obar JJ; Donovan DC; Crist SG; Silvia O; Stewart JP; Usherwood EJ
J Virol; 2004 Oct; 78(19):10829-32. PubMed ID: 15367651
[TBL] [Abstract][Full Text] [Related]
8. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.
Gangappa S; Kapadia SB; Speck SH; Virgin HW
J Virol; 2002 Nov; 76(22):11460-8. PubMed ID: 12388707
[TBL] [Abstract][Full Text] [Related]
9. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.
McClellan JS; Tibbetts SA; Gangappa S; Brett KA; Virgin HW
J Virol; 2004 Jul; 78(13):6836-45. PubMed ID: 15194759
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latency.
Weslow-Schmidt J; Ye F; Cush SS; Stuller KA; Blackman MA; Flaño E
J Virol; 2010 Sep; 84(17):8975-9. PubMed ID: 20592077
[TBL] [Abstract][Full Text] [Related]
11. Effective vaccination against long-term gammaherpesvirus latency.
Tibbetts SA; McClellan JS; Gangappa S; Speck SH; Virgin HW
J Virol; 2003 Feb; 77(4):2522-9. PubMed ID: 12551990
[TBL] [Abstract][Full Text] [Related]
12. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection.
Braaten DC; Sparks-Thissen RL; Kreher S; Speck SH; Virgin HW
J Virol; 2005 Feb; 79(4):2573-83. PubMed ID: 15681457
[TBL] [Abstract][Full Text] [Related]
13. Immune evasion by gamma-herpesviruses.
Stevenson PG
Curr Opin Immunol; 2004 Aug; 16(4):456-62. PubMed ID: 15245739
[TBL] [Abstract][Full Text] [Related]
14. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.
Tibbetts SA; van Dyk LF; Speck SH; Virgin HW
J Virol; 2002 Jul; 76(14):7125-32. PubMed ID: 12072512
[TBL] [Abstract][Full Text] [Related]
15. LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.
Lange PT; Jondle CN; Darrah EJ; Johnson KE; Tarakanova VL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602604
[TBL] [Abstract][Full Text] [Related]
16. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
17. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.
Coppola MA; Flaño E; Nguyen P; Hardy CL; Cardin RD; Shastri N; Woodland DL; Blackman MA
J Immunol; 1999 Aug; 163(3):1481-9. PubMed ID: 10415050
[TBL] [Abstract][Full Text] [Related]
18. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load.
Hoegh-Petersen M; Thomsen AR; Christensen JP; Holst PJ
Vaccine; 2009 Nov; 27(48):6723-30. PubMed ID: 19748577
[TBL] [Abstract][Full Text] [Related]
20. Early establishment of gamma-herpesvirus latency: implications for immune control.
Flaño E; Jia Q; Moore J; Woodland DL; Sun R; Blackman MA
J Immunol; 2005 Apr; 174(8):4972-8. PubMed ID: 15814726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
